Meenakshi Suku

Ms. Meenakshi Suku

PhD candidate

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2024 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Open access
RBRajiv Borah
Rajiv Borah
JOJulia O'SUllivan
Julia O'SUllivan
Meenakshi SukuMeenakshi Suku
Meenakshi Suku
DSDahnan Spurling
Dahnan Spurling
DCDaniel Diez Clarke
Daniel Diez Clarke
MMMichael Monaghan
Michael Monaghan
With no effective treatments for functional recovery after injury, spinal cord injury (SCI) remains one of the unresolved healthcare challenges. Human induced pluripotent stem cell (hiPSC) transplantation is a versatile patient‐specific regenerative approach for functional recovery after SCI. Injectable electroconductive hydrogel (ECH) can further enhance the cell transplantation efficacy through a minimally invasive manner as well as recapitulate the native bioelectrical microenvironment of neural tissue. Given these considerations, we report a novel ECH prepared through self‐assembly facilitated in situ gelation of natural silk fibroin (SF) derived from mulberry Bombyx mori silk and electrically conductive PEDOT:PSS. PEDOT:PSS was pre‐stabilized to prevent the potential delamination of its hydrophilic PSS chain under aqueous environment using 3% (v/v) (3‐glycidyloxypropyl)trimethoxysilane (GoPS) and 3% (w/v) poly(ethylene glycol)diglycidyl ether (PeGDE). The resultant ECH formulations are easily injectable with standard hand force with flow point below 100 Pa and good shear‐thinning properties. The ECH formulations with unmodified and GoPS‐modified PEDOT:PSS, that is, SF/PEDOT and SF/PEDOTGoP maintain comparable elastic modulus to spinal cord (~10–60 kPa) under physiological condition, indicating their flexibility. The GoPS‐modified ECHs also display improved structural recoverability (~70%–90%) as compared to the unmodified versions of the ECHs (~30%–80%), as indicated by the three interval time thixotropy (3ITT) test. Additionally, these ECHs possess electrical conductivity in the range of ~0.2–1.2 S/m comparable to spinal cord (1–10 S/m), indicating their ability to mimic native bioelectrical environment. Approximately 80% or more cell survival was observed when hiPSC‐derived cortical neurons and astrocytes were encapsulated within these ECHs. These ECHs support the maturation of cortical neurons when embedded for 7 days, fostering the development of a complex, interconnected network of long axonal processes and promoting synaptogenesis. These results underline the potential of silk ECHs in cell transplantation therapy for spinal cord regeneration.

22 December 2020 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Meenakshi SukuMeenakshi Suku
Meenakshi Suku
LLLaiva Ashang Luwang
Laiva Ashang Luwang
Fergal O'BrienFergal O'Brien
Fergal O'Brien
MKMichael Keogh
Michael Keogh
Skin wounds can lead to serious morbidity complications in diabetic patients due to the reduced healing potential of autologous stem cells. One reason for the low functional potency of stem cells from diabetic patients (diabetic stem cells) is attributed to their senescent-like nature. Here, we investigated if an anti-ageing protein, β-klotho, could be used to rejuvenate diabetic stem cells and to promote pro-angiogenic gene-activated scaffold (GAS)-induced functional response for wound healing applications. Human stem cells derived from the adipose tissue (adipose-derived stem cells (ADSCs)) of normal and diabetic (type 2) donors were used for the study. We report that the β-klotho priming facilitated inflammatory signal pruning by reducing interleukin-8 release by more than half while concurrently doubling the release of monocyte chemoattractant protein-1. Additionally, β-klotho priming enhanced the pro-angiogenic response of diabetic ADSCs on GAS by dampening the release of anti-angiogenic factors (i.e., pigment epithelium-derived factor, tissue inhibitor of metalloproteinase-1 and thrombospondin-1) while simultaneously supporting the expression of pro-angiogenic factors (i.e., Vascular Endothelial Growth Factor (VEGF), angiopoietin-2 and angiogenin). Finally, we show that β-klotho pre-treatment expedites the cellular expression of matrix proteins such as collagen IV and collagen VI, which are implicated in tissue maturation. Taken together, our study provides evidence that the synergistic effect of the pro-angiogenic GAS and β-klotho activation effectively accelerates the functional development of diabetic ADSCs for wound healing applications.

14 February 2026 in Biomaterials
Verified
Journal Article
Open access
RBRajiv Borah
Rajiv Borah
JOJulia O'SUllivan
Julia O'SUllivan
DSDahnan Spurling
Dahnan Spurling
AMAoife McLoughlin
Aoife McLoughlin
DADiana Eveline Sanchez Amador
Diana Eveline Sanchez Amador
MMMichael Monaghan
Michael Monaghan
Spinal cord injury (SCI) remains a major clinical challenge due to its complex pathophysiology and lack of effective treatments. While electrical stimulation (ES) offers therapeutic potential for promoting neural repair, its clinical translation is limited by the invasiveness of conventional systems. Here, we report a non-invasive wireless electrical stimulation (WES) platform based on charge polarisation-induced capacitive coupling, enabled by a conductive silk fibroin/PEDOT:PSS (SF/PEDOT) hydrogel. SF/PEDOT hydrogels exhibit a tuneable mechanical stiffness (2-120 kPa), injectable delivery (<5 N injection force), and electrical conductivity (∼0.3 S/m) closely matching the spinal cord. This hydrogel platform has low charge transfer resistance and enhanced capacitive behaviour, supporting efficient non-invasive capacitive coupling for secondary field transduction at low frequencies (∼10 kHz). Using this WES system, we demonstrated modulation of human blood-derived macrophages (hBDMs) toward a reparative phenotype, while downregulating pro-inflammatory markers even under inflammatory conditions. In parallel, hiPSC derived cortical astrocytes (CTX-ASTRO) encapsulated within SF/PEDOT hydrogels showed enhanced functional maturation under WES, evidenced by upregulated connexin 43 (Cx43) gap junction protein expression. In an in vitro SCI-like model of reactive astrogliosis, WES via SF/PEDOT partially mitigated astrocytic reactivity by reducing CXCL10, GM-CSF, and IL-6 secretion and increasing Cx43 expression. Conditioned media from WES treated CTX-ASTRO further suppressed pro-inflammatory activation of hBDMs. Together, these results provide the first evidence of the dual neuroprotective and immunomodulatory potential of a non-invasive, conductive hydrogel-based WES platform, validated using two human cell types specific to SCI pathophysiology. Thus, this approach offers a minimally invasive, translationally relevant solution for spinal cord repair via non-invasive neuromodulation.

7 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
Meenakshi SukuMeenakshi Suku
Meenakshi Suku
JMJack F. Murphy
Jack F. Murphy
SCSara Corbezzolo
Sara Corbezzolo
MBManus Biggs
Manus Biggs
GFGiancarlo Forte
Giancarlo Forte
MMMichael Monaghan
Michael Monaghan
Cardiovascular disease stands as the leading cause of death globally, claiming approximately 19million lives in 2020. On the contrary, the development of cardiovascular drugs is experiencing a decline, largely due to the bottleneck in understanding the pathophysiology of various heart diseases and assessing the effects of drugs on healthy human hearts. The development of induced pluripotent stem cell (iPSC) technology and the availability of cardiac cell types in vitro , has resulted in a surge in efforts to fabricate human cardiac models for disease modelling and drug discovery applications. Although numerous attempts evidence successful fabrication of 3 dimensional (3D) engineered heart tissues, the innate immune cell population of the myocardium – particularly cardiac macrophages, was until recently, overlooke. With increasing appreciation of the interactions between cardiomyocytes and macrophages in the myocardium, in this work, isogenic populations of cardiac resident-like macrophages and cardiomyocytes were generated using iPSCs, to understand the interactions between the two cell types in both 2D and 3D settings, and subjected to electric stimulation. After characterizing iPSC-derived macrophages (iMacs) and iPSC-derived cardiomyocytes (iCMs) in depth, the conditioning of iMacs to align to a cardiac resident macrophage-like phenotype in the presence of iCMs in 2D culture was explored. In co-culture with iCMs, iMacs upregulated known genes expressed by cardiac resident macrophages. Additionally, in co-culture with iMacs, iCMs displayed an elongated morphology, improved calcium function and an increase in known maturation genes such as the ratio between MYH7 and MYH6 as well as SERCA2. In a 2D setting, iMacs showed the ability to electrically couple with iCMs and facilitate synchronous beating in iCM cultures. The 2D characterisation was translated into an engineered cardiac tissue model, wherein, improvement in tissue characteristics in the presence of iMacs was demonstrated in terms of increased cell alignment, enhanced cardiomyocyte elongation, physiologically relevant beat rates and improved tissue compaction. Taken together, these findings may open new avenues to use iMacs in engineered cardiac tissue models, not only as an innate immune cell source, but also as a support cell type to improve cardiomyocyte function and maturation.